Graduate Certificate in Pharmacoeconomics - GradCertPharmEc

• General
• Course objectives
• Admission requirements
• Fees
• Duration
• Mode of offering
• Credit for work done previously
• Course structure

General

Course code: To be advised
Course director: Mr A Harris
This course by distance education has been designed to provide those involved in the pharmaceutical sector of health care with intensive training in the economic evaluation of pharmaceuticals and pharmaceutical policy. The economic analysis of pharmaceutical development and utilisation is of interest those involved in the production, use, delivery and regulation of pharmaceuticals. The need for economic evaluation of products and policy in this area is well recognised not least by the requirement in Australia and elsewhere for economic evaluation of new pharmaceuticals prior to public reimbursement. The course is taught by people with experience in the economic and clinical evaluation of pharmaceuticals in industry, government and academia. The course provides students with the critical capacity to examine a range of economic issues in the pharmaceutical industry including the economics of production, regulation, and pricing as well as an assessment of the efficacy, effectiveness and cost effectiveness of individual pharmaceutical products.

Course objectives

The objectives of the course focus on six key areas of study through which the students will be able to:

• use their knowledge of the institutional arrangements for the financing and delivery of health care services in Australia, including pharmaceuticals, to discuss alternative arrangements from an economic perspective
• develop an economic way of thinking and appreciate and the role of economic incentives in the achievement of health care objectives and articulate the usefulness of economic analysis in promoting an efficient and equitable health care system
• understand the economic and social influences on global drug development and marketing including the issues of drug research and development, the role of patents, the structure of the pharmaceutical industry, profitability and international competition
• understand and apply the theory and techniques of economic evaluation, epidemiology and biostatistics to the design of a clinical trial of a drug with a parallel economic analysis
• develop an understanding of the concepts of health outcome measurement and its role in economic evaluation and become familiar with the measurement techniques in health outcome research including health status measurement, valuing time and productivity, and willingness to pay for health gains
• apply the theory of decision analysis, Monte Carlo and Markov modeling to the evaluation of pharmaceutical use.

Admission requirements

Applicants require a pass degree or an equivalent qualification from a recognised tertiary institution plus a minimum of two years relevant employment experience.

Fees

This is a fee-paying course. Candidates should refer to the faculty office Clayton as to the 1999 course fee. Course fees are set and reviewed annually and are therefore subject to change.

Duration

The Graduate Certificate in Pharmacoeconomics is normally completed in two semesters of part-time study.

Mode of offering

This course is offered by distance education from the Department of Economics.

Credit for work done previously

Candidates may be eligible for a maximum of two credit exemptions for subjects considered to be equivalent to particular subjects in the course of study. Please refer to the course director for further details.

Course structure

The course consists of four core subjects.

• ECG9101 Economic policy
• MPH1xxx Epidemiology and biostatistics
• ECC9700 Introduction to health economics
• ECC9710 Pharmaceutical economics.

wwwdev@monash.edu.au Wed Dec 2 13:01:52 EST 1998
Auth: C Whip, University Webmaster's Office
Copyright © Monash University 1998 - All Rights Reserved - Caution